• Profile
Close

MicroRNA-139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL

The Prostate Jul 12, 2019

Nam RK, et al. - Via a cohort of 585 patients treated with radical prostatectomy, researchers investigated the mechanism of action of miR-139-5p, one of the downregulated microRNAs (miRNAs) recognized in a panel of five microRNAs (miRNAs) associated with biochemical recurrence and metastasis following prostatectomy. In prostate cancer, low miR-139 expression was markedly affiliated with many prognostic factors, including Gleason score, pathologic stage, margin positivity, and lymph node status. Among patients with high miR-139 expression, the cumulative incidence of biochemical recurrence and metastasis were significantly decreased. In comparison with control cells, a significant decrease in cell proliferation and migration was observed with the overexpression of miR-139 in prostate cancer cells with cells arrested in G2 of the cell cycle. IGF1R and AXL protein expression were repressed by miR-139 treatment, and it was reversed via the addition of miR-139 antagomir. In patients with localized prostate cancer, miR-139 was correlated with better prognosis, which could be mediated through the downregulation of IGF1R and/or AXL and associated signaling pathway components.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay